Supplementary Results

Supplementary
(0.75%) and ɸ16 (0.72%), the higher the probability of its rescuing. 
Supplementary Methods
Construction of vectors G1RL0 and G1RCMsKp
For the construction of the G1RL0 vector, five mutations were sequentially introduced into the G1RC 1 vector. Two of them (C140T and A194G) were introduced at once, following a method previously described 2 , while the other three (A394G, C473T, C647A) were individually introduced, using the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies). All introduced mutations were confirmed by sequencing using vector-derived external primers. The list of primers is provided in Supplementary Table 7 .
For the construction of the G1RCMsKp vector, the same site-directed mutagenesis procedure was used to introduce restriction sites for the MscI and KpnI enzymes between the IRES and the FLuc gene. All introduced restriction sites were confirmed by sequencing using vector-derived external primers.
Primers used are shown in Supplementary Table 7.
Figure S1. G1RL0 and G1RCMsKp vectors.
Recognition by H7C27 and K34C8 monoclonal antibodies.
Virus stocks used in the analysis of recognition by antibodies were treated with 1% NP-40 for 30 min at 37ºC. Viruses recovered in the supernatants were subjected to three 30-s sonication cycles of at 60 W.
H7C27 mAb recognizes the glycophorin A binding site 3, 4 while K34C8 mAb is directed against the immunodominant site 3 . While H7C27 epitope is present in the protomers, procapsids and capsids, the epitope recognized by the K34C8 mAb is present only in procapsids and capsids 5 . For the recognition with each individual mAb an indirect sandwich ELISA was performed 6 , in which particles were captured by a convalescent-phase serum and detected with H7C27 or K34C8 mAbs. All mAbs were used at the highest dilution (1/10000) yielding recognition and were detected using a labeled anti-mouse IgG. An average of 1.5 x 10 6 TCID50 per well was used.
Recognition of virus stocks by a polyclonal convalescent serum was also tested. A direct sandwich ELISA was performed in which particles were captured and detected with the same convalescent-phase serum. In the detection step the antibodies from the convalescent-phase serum were labeled and used at the highest dilution (1/1400) yielding recognition.
A cut-off level was established corresponding to the mean ± 3 SD of the unspecific recognition of mock-infected FRhK-4 cell extracts. Three different
stocks of each population were tested twice.
Physical Stability.
Treatments at 61ºC for 5 min, pH 2 for 1h at 37ºC and 1% biliary salts for 4h at 37ºC were performed and the resistance of each population evaluated as previously described 7 . To quantify virus decay, a control test of non-treated viruses kept for the same length of time at 37°C was run in parallel. The Log10 reduction of the virus titer after each treatment (Nt) compared with the infectious titer of the parallel non-treated virus control (N0) was figured. Three different
stocks for each population were tested and all samples were titrated twice.
Sucrose-Iodixanol gradients
Infected cell culture supernatant fluids were centrifuged at 1,500 x g for 10 minutes at 4°C to pellet any cellular debris and further clarified by centrifuging twice at 10,000 X g for 30 minutes at 4°C. Viruses were further concentrated by ultracentrifugation at 100,000 X g for 1 hour at 4°C. Finally, the resulting pellet was resuspended in 1 ml of phosphate-buffered saline and briefly sonicated, loaded onto a pre-formed 6-50% iodixanol-(OptiPrep, Axis-Shield) sucrose step gradient, and then centrifuged at 205,000 X g for 2 hours and 45 minutes at 4°C
using an SW41 Ti rotor in a Beckman Coulter Optima L-90K Ultracentrifuge.
Later, approximately 20 fractions of 0.5 ml each were collected from the gradient and the density of each fraction was determined using a refractometer.
RNA from gradient fractions was extracted using the Nucleospin RNA Virus Extraction Kit (Macherey-Nagel) and HAV genome copy numbers were determined by real-time qRT-PCR as previously described 8 
Statistical analysis.
Statistical differences between the different virus populations regarding virus production/cell, plaque diameter, monoclonal and polyclonal antibodies recognition and physical stability were assessed using the Student's t-test (twosided), after verifying the normality of data with the Kolmogorov-Smirnov test.
Supplementary Table 7 . List of primers used for: the modification of the vector G1RC, the introduction of IRES mutations and cloning of VP1 fragments. In bold nucleotides involved in site-directed mutagenesis.
Underlined Kpn I restriction site. Mut primers are those used in the confirmation sequencing.
Primer Sequence
G1RC modification into G1RL0
C140T A149G+
5'CCCTTTGTTTTGTTTGTAAATGTTGATTTGTAAATATTGATTCCTGCAGGTTC3'
G1RC modification into G1RCMsKp
Incorporation of IRES mutations found in the haplotypes into G1RL0 vector
Amplification of the VP1 fragment
Incorporation of (U359C, U590C, U726C) IRES mutations in VP1-bearing vectors 
